Skip to main content

Table 2 Direct costs (US$) per hypertensive inpatient by disease classification and cost category

From: Direct costs of hypertensive patients admitted to hospital in Vietnam’ a bottom-up micro-costing analysis

Cost category Median (and IQR) of costs Mean (± SD) of costs % of total costs of all patients % of total costs of I10 group % of total costs of I10 combine E75
All patients (n = 230) I10 group (n = 147) I10 combined E75 group (n = 83) All patients (n = 230) I10 group (n = 147) I10 combined E75 group (n = 83)
Inpatient days 29.94 (14.97 - 39.92) 24.95 (9.98 - 34.93) 34.93 (24.95 - 44.91) 29.05 (±16.45) 24.86 (±15.94) 36.48 (±14.69) 41.37 40.01 43.14
Drugs 11.67 (4.63 - 39.76) 8.26 (3.69 - 37.02) 16.13 (8.47 - 51.47) 23.85 (±25.4) 21.24 (±25.26) 28.45 (±25.12) 33.96 34.19 33.65
Tests 13.00 (6.89 - 19.24) 11.56 (5.62 - 15.76) 13.69 (7.81 - 25.76) 15.84 (±13.88) 14.49 (±13.46) 18.22 (±14.37) 22.55 23.33 21.54
Others 1.23 (0.84 - 1.68) 1.17 (0.82 - 1.56) 1.41 (0.85 - 1.83) 1.49 (±2.26) 1.53 (±2.79) 1.41 (±0.6) 2.12 2.47 1.67
Total costs 64.95 (37.18 - 95.32) 53.41 (29.71 - 82.82) 77.64 (56.61 ±106.5) 70.23 (±42.89) 62.13 (±43.76) 84.56 (±37.46) 100 100 100